// App-Quantinova.ai

e15672 : Does OPTINAB strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel (nab) - gemcitabine (gem)?

Researchers

Presenter

  • Wasif M. Saif

Principal Investigators

  • Valerie Relias

  • Sanjay Hegde

  • Douglas W Hackenyos

  • Lisa Ralph

  • Antonia Maloney

  • Melissa H Smith

  • Martin D. Goodman

Medical Centers

  • Tufts University School of Medicine, Tufts Cancer Center, Boston, MA

  • Tufts University School of Medicine, Tufts Cancer Center, Boston, MA

  • Tufts Medical Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Peripheral neuropathy

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Carbohydrate antigen 19-9

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved